P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1064-1065
10.1097/01.hs9.0000847576.88118.d6